Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Um estudo para avaliar a mudança na atividade da doença e eventos adversos do upadacitinibe oral em participantes adultos e adolescentes com hidradenite supurativa moderada a grave que falharam na terapia anti-TNF (Step-Up HS)

10 de novembro de 2026 atualizado por: AbbVie

Um estudo de fase 3, randomizado, controlado por placebo, duplo-cego para avaliar a eficácia e a segurança do upadacitinibe em adultos e adolescentes com hidradenite supurativa moderada a grave que falharam na terapia anti-TNF

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how safe and effective upadacitinib is in treating adult and adolescent participants with moderate to severe HS who have failed to respond to or are intolerant of anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed.

Upadacitinib is an approved drug for ulcerative colitis, atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, and axial spondylarthritis and is being developed for the treatment of HS. This study is "double-blinded", meaning that neither the trial participants nor the study doctors will know who will be given upadacitinib and who will be given placebo. This study is comprised of 3 periods. In Period 1, participants are randomized into 2 groups called treatment arms where each group receives a different treatment. There is a 1 in 2 chance that participants will be assigned to placebo. In Period 2, participants are placed into 6 different groups depending on their placement and results in Period 1. Period 3 is the long-term extension period where participants will continue treatment from Period 2. Approximately 1328 adult and adolescent participants diagnosed with HS will be enrolled in approximately 300 sites worldwide.

Participants will receive oral tablets of upadacitinib or placebo once daily for 36 weeks in Period 1 and Period 2. Eligible participants from Period 1 and Period 2 will enter Period 3 and receive oral tablets of upadacitinib or placebo once daily for 68 weeks. Participants will be followed up for approximately 30 days.

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular outpatient visits during the study. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.

Visão geral do estudo

Status

Ativo, não recrutando

Tipo de estudo

Intervencional

Inscrição (Estimado)

1328

Estágio

  • Fase 3

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Berlin, Alemanha, 13595
        • Havelklinik /ID# 254194
      • Magdeburg, Alemanha, 39104
        • Magdeburger Company for Medical Studies & Services GmbH /ID# 255151
      • Mainz, Alemanha, 55128
        • Dermatologie Quist-BAG Dres. med. Quist PartG /ID# 253691
    • Baden-Wurttemberg
      • Freiburg im Breisgau, Baden-Wurttemberg, Alemanha, 79106
        • Universitaetsklinikum Freiburg /ID# 275746
    • Bavaria
      • Erlangen, Bavaria, Alemanha, 91054
        • Universitaetsklinikum Erlangen /ID# 254804
      • Munich, Bavaria, Alemanha, 80802
        • Klinikum rechts der Isar Technische Universitat Munchen /ID# 254195
      • Regensburg, Bavaria, Alemanha, 93042
        • Universitaetsklinikum Regensburg /ID# 253692
      • Würzburg, Bavaria, Alemanha, 97080
        • Universitaetsklinikum Wuerzburg /ID# 275599
    • Hesse
      • Frankfurt am Main, Hesse, Alemanha, 60590
        • Universitaetsklinikum Frankfurt /ID# 253683
    • Lower Saxony
      • Bad Bentheim, Lower Saxony, Alemanha, 48455
        • Fachklinik - Bad Bentheim /ID# 275537
      • Bramsche, Lower Saxony, Alemanha, 49565
        • Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 254510
    • North Rhine-Westphalia
      • Bochum, North Rhine-Westphalia, Alemanha, 44791
        • Universitaetsklinikum Der Ruhr-Universitaet Bochum /ID# 253690
      • Düsseldorf, North Rhine-Westphalia, Alemanha, 40225
        • Universitaetsklinikum Duesseldorf /ID# 253711
    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Alemanha, 55131
        • Universitaetsmedizin Mainz /ID# 272596
    • Saarland
      • Merzig, Saarland, Alemanha, 66663
        • Hautmedizin Saar Science /ID# 272614
      • Buenos Aires, Argentina, 1061
        • Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 255474
      • CABA, Argentina, C1199ABB
        • Hospital Italiano /ID# 254905
    • Buenos Aires
      • Pilar, Buenos Aires, Argentina, 1629
        • Hospital Universitario Austral /ID# 254904
    • Buenos Aires F.D.
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1055
        • Buenos Aires Skin /ID# 255299
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1425
        • Instituto de Neumonologia y Dermatologia /ID# 254903
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1425
        • Psoriahue Med Interdisciplinar /ID# 257202
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1428
        • Consultorios Reumatologicos Pampa /ID# 255555
      • Riyadh, Arábia Saudita, 12372
        • King Saud University Med City /ID# 255282
    • Mecca Region
      • Jeddah, Mecca Region, Arábia Saudita, 23433
        • King Faisal Specialist Hospital /ID# 255539
    • Riyadh Region
      • Riyadh, Riyadh Region, Arábia Saudita, 11211
        • King Faisal Specialist Hospital and Research Centre /ID# 255279
      • Riyadh, Riyadh Region, Arábia Saudita, 11426
        • King Abdulaziz Medical City- National Guard Hospital /ID# 255280
    • Australian Capital Territory
      • Phillip, Australian Capital Territory, Austrália, 2606
        • Paratus Clinical Research Woden /ID# 254670
    • New South Wales
      • Darlinghurst, New South Wales, Austrália, 2010
        • Momentum Clinical Research /ID# 254411
    • Victoria
      • Carlton, Victoria, Austrália, 3053
        • Skin Health Institute Inc /ID# 254416
      • East Melbourne, Victoria, Austrália, 3002
        • Sinclair Dermatology - Melbourne /ID# 254412
      • Melbourne, Victoria, Austrália, 3004
        • The Alfred Hospital /ID# 254414
      • Rio de Janeiro, Brasil, 20241-180
        • Instituto Brasil de Pesquisa Clinica S.A - IBPClin /ID# 275810
      • São Paulo, Brasil, 05403-000
        • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 254370
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasil, 90035-001
        • Hospital Moinhos de Vento /ID# 254366
    • Rio de Janeiro
      • Macaé, Rio de Janeiro, Brasil, 27910-190
        • Instituto de Pesquisa e Ensino CLIGEDIMUNO - IPEC /ID# 254369
    • São Paulo
      • Campinas, São Paulo, Brasil, 13034-685
        • Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 275811
      • Ribeirão Preto, São Paulo, Brasil, 14049-900
        • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 254367
      • São Paulo, São Paulo, Brasil, 04020-060
        • Centro de Desenvolvimento em Estudos Clinicos Brasil - CDEC /ID# 254368
      • Sofia, Bulgária, 1407
        • Acibadem City Clinic Tokuda University Hospital EAD /ID# 253331
      • Stara Zagora, Bulgária, 6000
        • UMHAT Professor Stoyan Kirkovich /ID# 253328
    • Sofia
      • Sofiya, Sofia, Bulgária, 1407
        • Ambulatory for Specialized Medical Care-IPSMC-skin and venereal diseases /ID# 253329
      • Sofiya, Sofia, Bulgária, 1463
        • Diagnostic Consultative Centre (Dcc) - Foкus 5 /ID# 253327
      • Liège, Bélgica, 4000
        • CHU de Liege /ID# 254085
    • Brussels Capital
      • Anderlecht, Brussels Capital, Bélgica, 1070
        • Universite Libre de Bruxelles - Hopital Erasme /ID# 254082
      • Brussels, Brussels Capital, Bélgica, 1200
        • Cliniques Universitaires UCL Saint-Luc /ID# 254087
      • Jette, Brussels Capital, Bélgica, 1090
        • Universitair Ziekenhuis Brussel /ID# 254223
    • Hainaut
      • Charleroi, Hainaut, Bélgica, 6280
        • Grand Hopital de Charleroi - Les Viviers /ID# 254091
    • Oost-Vlaanderen
      • Ghent, Oost-Vlaanderen, Bélgica, 9000
        • UZ Gent /ID# 254090
    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Bélgica, 3000
        • Universitair Ziekenhuis Leuven /ID# 254089
      • Québec, Canadá, G1V 4T3
        • Diex Recherche Quebec Inc. /ID# 254381
    • Alberta
      • Calgary, Alberta, Canadá, T2J 7E1
        • Dermatology Research Institute - Blackfoot Trail /ID# 261413
      • Calgary, Alberta, Canadá, T3A 2N1
        • Beacon Dermatology /ID# 254564
      • Edmonton, Alberta, Canadá, T5J 3S9
        • Rejuvenation Dermatology - Edmonton Downtown /ID# 254715
      • Edmonton, Alberta, Canadá, T6G 1C3
        • Alberta Dermasurgery Centre /ID# 275945
      • Red Deer, Alberta, Canadá, T4P 1K4
        • Care Clinic - Red Deer - Taylor Drive /ID# 276063
    • British Columbia
      • Surrey, British Columbia, Canadá, V3R 6A7
        • Dr. Chih-ho Hong Medical Inc. /ID# 254378
      • Surrey, British Columbia, Canadá, V3V 0C6
        • Enverus Medical Research /ID# 254380
    • Manitoba
      • Winnipeg, Manitoba, Canadá, R3M 3Z4
        • Wiseman Dermatology Research /ID# 254117
    • Newfoundland and Labrador
      • St. John's, Newfoundland and Labrador, Canadá, A1A 4Y3
        • Karma Clinical Trials /ID# 254120
    • Ontario
      • Hamilton, Ontario, Canadá, L8L 3C3
        • LEADER Research /ID# 254379
      • London, Ontario, Canadá, N6H 5L5
        • DermEffects /ID# 254116
      • Markham, Ontario, Canadá, L3P 1X2
        • Lynderm Research /ID# 254713
      • Mississauga, Ontario, Canadá, L4W 0C2
        • Derm Care Clinic /ID# 276065
      • Newmarket, Ontario, Canadá, L3Y 5G8
        • Ryan Clinical Research Inc /ID# 254714
      • Richmond Hill, Ontario, Canadá, L4C 9M7
        • York Dermatology Clinic and Research Centre /ID# 254115
      • Toronto, Ontario, Canadá, M4W 2N4
        • Research Toronto /ID# 255273
    • Quebec
      • Montreal, Quebec, Canadá, H3T 1C5
        • Centre Hospitalier Universitaire (CHU) Sainte-Justine /ID# 254118
      • Saint-Jérôme, Quebec, Canadá, J7Z 7E2
        • Dre Angelique Gagne-Henley M.D. inc. /ID# 255632
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canadá, S7K 0H6
        • SkinSense Dermatology /ID# 254119
    • Region Metropolitana Santiago
      • Las Condes, Region Metropolitana Santiago, Chile, 7580206
        • Centro Medico Skin Med SPA /ID# 254560
      • Santiago, Region Metropolitana Santiago, Chile, 8420383
        • Centro Internacional de Estudios Clinicos - CIEC /ID# 254559
      • Vitacura, Region Metropolitana Santiago, Chile, 7640881
        • Clinica Dermacross /ID# 254558
    • Santiago Metropolitan
      • Independencia, Santiago Metropolitan, Chile, 8380465
        • Fundacion Innovacion Cardiovascular /ID# 254561
      • Singapore, Cingapura, 119074
        • National University Hospital /ID# 254943
    • Central Singapore
      • Singapore, Central Singapore, Cingapura, 308205
        • National Skin Centre /ID# 255242
    • Antioquia
      • Medellín, Antioquia, Colômbia, 050012
        • Clinica De Inmunologia Y Genetica (Cige) /ID# 254797
      • Medellín, Antioquia, Colômbia, 050016
        • IPS Suramericana SAS - IPS Sura San Diego /ID# 255064
    • Atlántico
      • Barranquilla, Atlántico, Colômbia, 80002
        • Centro Integral de Reumatologia del Caribe SAS - Circaribe SAS /ID# 255278
    • Cundinamarca
      • Bogotá, Cundinamarca, Colômbia, 110221
        • Centro de Investigacion en Reumatologia y especialidades Medicas S.A.S- CIREEM /ID# 254796
    • Gyeonggido
      • Ansan-si, Gyeonggido, Coréia do Sul, 15355
        • Korea University Ansan Hospital /ID# 254128
      • Seongnam, Gyeonggido, Coréia do Sul, 13496
        • CHA Bundang Medical Center /ID# 254026
    • Seoul Teugbyeolsi
      • Seoul, Seoul Teugbyeolsi, Coréia do Sul, 03080
        • Seoul National University Hospital /ID# 254027
      • Seoul, Seoul Teugbyeolsi, Coréia do Sul, 04401
        • SoonChunHyang University Seoul Hospital /ID# 254025
      • Seoul, Seoul Teugbyeolsi, Coréia do Sul, 07441
        • Hallym University Kangnam Sacred Heart Hospital /ID# 254127
    • City of Zagreb
      • Zagreb, City of Zagreb, Croácia, 10000
        • DermaPlus - Poliklinika za dermatologiju i venerologiju /ID# 253587
      • Zagreb, City of Zagreb, Croácia, 10000
        • Klinicki bolnicki centar Zagreb /ID# 253786
      • Zagreb, City of Zagreb, Croácia, 10000
        • Klinika za dječje bolesti Zagreb /ID# 253588
      • Zagreb, City of Zagreb, Croácia, 10000
        • Poliklinika Solmed /ID# 254732
    • Primorje-Gorski Kotar County
      • Rijeka, Primorje-Gorski Kotar County, Croácia, 51000
        • Specialty Hospital Medico /ID# 254731
    • Split-Dalmatia County
      • Split, Split-Dalmatia County, Croácia, 21000
        • Klinicki Bolnicki Centar Split /ID# 253789
    • Zagreb County
      • Ivanić-Grad, Zagreb County, Croácia, 10310
        • Naftalan - Specijalna bolnica za medicinsku rehabilitaciju /ID# 253586
    • Bratislava Region
      • Bratislava, Bratislava Region, Eslováquia, 821 01
        • Univerzitna nemocnica Bratislava - Nemocnica Ruzinov /ID# 254157
    • Košice Region
      • Košice, Košice Region, Eslováquia, 041 90
        • Univerzitna nemocnica L. Pasteura Kosice /ID# 254136
    • Nitra Region
      • Nové Zámky, Nitra Region, Eslováquia, 940 34
        • Fakultna nemocnica s poliklinikou Nove Zamky /ID# 254155
    • Trnava Region
      • Trnava, Trnava Region, Eslováquia, 917 02
        • Fakultna nemocnica Trnava /ID# 254137
    • Žilina Region
      • Martin, Žilina Region, Eslováquia, 036 01
        • Univerzitna nemocnica Martin /ID# 254153
      • Barcelona, Espanha, 08041
        • Hospital Santa Creu i Sant Pau /ID# 253869
      • Barcelona, Espanha, 08042
        • Hospital General de Granollers /ID# 253873
      • Granada, Espanha, 18014
        • Hospital Universitario Virgen de las Nieves /ID# 253870
      • Madrid, Espanha, 28034
        • Hospital Universitario Ramon y Cajal /ID# 253871
      • Valencia, Espanha, 46026
        • Hospital Universitario y Politecnico La Fe /ID# 253868
    • Barcelona
      • L'Hospitalet de Llobregat, Barcelona, Espanha, 08907
        • Hospital Universitari de Bellvitge /ID# 254982
    • Madrid
      • Majadahonda, Madrid, Espanha, 28222
        • Hospital Universitario Puerta de Hierro - Majadahonda /ID# 253924
    • Valencia
      • Manises, Valencia, Espanha, 46940
        • Hospital de Manises /ID# 253867
    • Alabama
      • Birmingham, Alabama, Estados Unidos, 35244
        • Cahaba Dermatology and Skin Health Center /ID# 254876
    • Arizona
      • Fountain Hills, Arizona, Estados Unidos, 85268
        • Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564
      • Phoenix, Arizona, Estados Unidos, 85006
        • Medical Dermatology Specialists /ID# 254226
      • Scottsdale, Arizona, Estados Unidos, 85259
        • Mayo Clinic Hospital Scottsdale /ID# 254388
      • Tucson, Arizona, Estados Unidos, 85718-1407
        • Banner University Medicine Dermatology /ID# 255853
    • Arkansas
      • Fayetteville, Arkansas, Estados Unidos, 72703
        • Clinical Trials Institute - Northwest Arkansas /ID# 254924
      • Hot Springs, Arkansas, Estados Unidos, 71913-6404
        • Burke Pharmaceutical Research /ID# 254238
      • North Little Rock, Arkansas, Estados Unidos, 72217
        • Arkansas Research Trials /ID# 254233
      • Rogers, Arkansas, Estados Unidos, 72758
        • Northwest Arkansas Clinical Trials Center /ID# 254311
    • California
      • Encino, California, Estados Unidos, 91436
        • Private Practice - Dr. Tooraj Raoof /ID# 254374
      • Huntington Beach, California, Estados Unidos, 92647
        • Marvel Clinical Research /ID# 276228
      • Los Angeles, California, Estados Unidos, 90045
        • Dermatology Research Associates /ID# 254846
      • Rocklin, California, Estados Unidos, 95765
        • Norcal Clinical Research /ID# 274219
      • Sacramento, California, Estados Unidos, 95815
        • Integrative Skin Science and Research /ID# 254930
      • Sacramento, California, Estados Unidos, 95817
        • University of California Davis Health /ID# 254229
      • San Diego, California, Estados Unidos, 92103
        • Medderm Associates /ID# 253800
      • Thousand Oaks, California, Estados Unidos, 91320-2130
        • Clinical Trials Research Institute /ID# 254466
    • Connecticut
      • Farmington, Connecticut, Estados Unidos, 06032
        • UConn Health Main /ID# 254507
      • New Haven, Connecticut, Estados Unidos, 06510
        • Yale University School of Medicine /ID# 254586
    • Florida
      • Boca Raton, Florida, Estados Unidos, 33486-2269
        • Skin Care Research Boca Raton /ID# 253814
      • Brandon, Florida, Estados Unidos, 33511
        • Apex Clinical Trials /ID# 255756
      • Coral Gables, Florida, Estados Unidos, 33134-5755
        • Florida Academic Dermatology Center /ID# 254011
      • Coral Springs, Florida, Estados Unidos, 33071
        • Life Clinical Trials - Coral Springs /ID# 258613
      • Delray Beach, Florida, Estados Unidos, 33445
        • Dermatology Associates of the Palm Beaches /ID# 275950
      • Hollywood, Florida, Estados Unidos, 33021-6748
        • Skin Care Research - Hollywood /ID# 254508
      • Tampa, Florida, Estados Unidos, 33607-6438
        • Skin Care Research - Tampa /ID# 256440
      • Tampa, Florida, Estados Unidos, 33607
        • Advanced Clinical Research Institute - Tampa /ID# 253746
      • Tampa, Florida, Estados Unidos, 33613-1825
        • Avita Clinical Research /ID# 254471
    • Georgia
      • Columbus, Georgia, Estados Unidos, 31904-2954
        • Centricity Research - Columbus /ID# 255470
    • Idaho
      • Boise, Idaho, Estados Unidos, 83706
        • Treasure Valley Medical Research /ID# 255208
    • Illinois
      • Chicago, Illinois, Estados Unidos, 60602
        • Illinois Dermatology Institute - Chicago Loop Office /ID# 254372
      • Chicago, Illinois, Estados Unidos, 60611
        • Northwestern Medicine - Northwestern Memorial Hospital /ID# 254503
      • Skokie, Illinois, Estados Unidos, 60077
        • NorthShore University HealthSystem - Skokie /ID# 254389
    • Indiana
      • Indianapolis, Indiana, Estados Unidos, 46256
        • Dawes Fretzin /ID# 254390
      • West Lafayette, Indiana, Estados Unidos, 47906
        • Options Research Group /ID# 254537
    • Kansas
      • Leawood, Kansas, Estados Unidos, 66211-1453
        • U.S. Dermatology Partners Leawood /ID# 255838
    • Kentucky
      • Bowling Green, Kentucky, Estados Unidos, 42104
        • Equity Medical /ID# 271140
    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02114
        • Massachusetts General Hospital /ID# 261093
      • Boston, Massachusetts, Estados Unidos, 02215-5400
        • Beth Israel Deaconess Medical Center /ID# 253811
      • Quincy, Massachusetts, Estados Unidos, 02169
        • Beacon Clinical Research, LLC /ID# 254419
      • Worcester, Massachusetts, Estados Unidos, 01655
        • UMass Memorial Medical Center - Lake Avenue North /ID# 258839
    • Michigan
      • Caledonia, Michigan, Estados Unidos, 49316
        • The Derm Institute Of West Michigan /ID# 275948
      • Canton, Michigan, Estados Unidos, 48187
        • Hamzavi Dermatology - Canton /ID# 275856
      • Clarkston, Michigan, Estados Unidos, 48346
        • Michigan Center for Medical Research - Clarkston /ID# 275860
      • Waterford, Michigan, Estados Unidos, 48328
        • Michigan Dermatology Institute /ID# 254468
    • Missouri
      • Kirksville, Missouri, Estados Unidos, 63501-5362
        • Cleaver Dermatology /ID# 254391
      • Lee's Summit, Missouri, Estados Unidos, 64064-2301
        • Dermatology and Skin Center of Lees Summit /ID# 257546
      • Saint Joseph, Missouri, Estados Unidos, 64506
        • MediSearch Clinical Trials /ID# 254392
      • St Louis, Missouri, Estados Unidos, 63104
        • SSM Health Saint Louis University Hospital /ID# 256437
      • St Louis, Missouri, Estados Unidos, 63130
        • Washington University School of Medicine - St. Louis /ID# 254506
    • Nevada
      • Las Vegas, Nevada, Estados Unidos, 89119-5190
        • Vivida Dermatology- Flamingo /ID# 254227
      • Las Vegas, Nevada, Estados Unidos, 89144
        • Las Vegas Dermatology /ID# 272421
      • Reno, Nevada, Estados Unidos, 89509
        • Skin Cancer and Dermatology Institute - Reno /ID# 254410
    • New York
      • East Syracuse, New York, Estados Unidos, 13057
        • Empire Dermatology /ID# 276241
      • New Hyde Park, New York, Estados Unidos, 11042-2058
        • NorthWell Health - Dermatology /ID# 254704
      • New York, New York, Estados Unidos, 07044-2946
        • Schweiger Dermatology, P.C. /ID# 254232
      • New York, New York, Estados Unidos, 10012
        • Private Practice - Dr. Bobby Buka /ID# 276371
    • North Carolina
      • Charlotte, North Carolina, Estados Unidos, 28277
        • OnSite Clinical Solutions - North Community House Road - Charlotte /ID# 254854
      • Durham, North Carolina, Estados Unidos, 27710
        • Duke University Medical Center /ID# 256898
    • Ohio
      • Canton, Ohio, Estados Unidos, 44718
        • Apex Clinical Research Center, LLC /ID# 275956
      • Columbus, Ohio, Estados Unidos, 43213-4440
        • ClinOhio Research Services /ID# 254851
      • Mason, Ohio, Estados Unidos, 45040-4520
        • Dermatologists of Southwest Ohio /ID# 254297
      • Medina, Ohio, Estados Unidos, 44256
        • Dermatology Partners - Medina /ID# 275939
    • Oklahoma
      • Oklahoma City, Oklahoma, Estados Unidos, 73112
        • Lynn Institute of Oklahoma City /ID# 253791
    • Oregon
      • Portland, Oregon, Estados Unidos, 97239
        • Oregon Health and Science University /ID# 254929
    • Pennsylvania
      • Hershey, Pennsylvania, Estados Unidos, 17033-2360
        • Penn State Milton S. Hershey Medical Center /ID# 254925
      • Philadelphia, Pennsylvania, Estados Unidos, 19103
        • Paddington Testing Co., Inc. /ID# 254394
      • Philadelphia, Pennsylvania, Estados Unidos, 19114
        • Clinical Research of Philadelphia, LLC /ID# 255308
    • South Carolina
      • Charleston, South Carolina, Estados Unidos, 29425
        • Medical University of South Carolina /ID# 272569
    • Tennessee
      • Knoxville, Tennessee, Estados Unidos, 37917
        • Dermatology Associates of Knoxville /ID# 261082
    • Texas
      • Arlington, Texas, Estados Unidos, 76011
        • Arlington Research Center, Inc /ID# 253805
      • Bellaire, Texas, Estados Unidos, 77401
        • Bellaire Dermatology Associates /ID# 253797
      • Dallas, Texas, Estados Unidos, 75230
        • Dermatology Treatment and Research Center /ID# 253795
      • Dallas, Texas, Estados Unidos, 75231
        • Modern Research Associates /ID# 253810
      • Dallas, Texas, Estados Unidos, 75240-6246
        • HRMD Research Dallas /ID# 255256
      • Grapevine, Texas, Estados Unidos, 76051-3580
        • Dallas Fort Worth Clinical Research Associates (DFWCRA) /ID# 256438
      • Houston, Texas, Estados Unidos, 77056
        • Suzanne Bruce and Associates-Houston /ID# 254228
      • Plano, Texas, Estados Unidos, 75025
        • Texas Dermatology Research Center /ID# 254928
      • Webster, Texas, Estados Unidos, 77598
        • Center for Clinical Studies Webster /ID# 254242
    • Utah
      • Bountiful, Utah, Estados Unidos, 84010
        • Cope Family Medicine - Ogden Clinic /ID# 276227
      • Murray, Utah, Estados Unidos, 84107
        • University of Utah - Murray /ID# 254452
      • Springville, Utah, Estados Unidos, 84663
        • Springville Dermatology - Springville /ID# 276225
    • Virginia
      • Charlottesville, Virginia, Estados Unidos, 22903
        • University of Virginia - Dermatology /ID# 254535
      • Lynchburg, Virginia, Estados Unidos, 24501-1403
        • The Education & Research Foundation, Inc. /ID# 254852
      • Norfolk, Virginia, Estados Unidos, 23507
        • Virginia Clinical Research /ID# 254538
    • Washington
      • Mill Creek, Washington, Estados Unidos, 98012
        • Frontier Dermatology /ID# 254554
      • Spokane, Washington, Estados Unidos, 99202
        • Premier Clinical Research /ID# 254847
    • North Ostrobothnia
      • Oulu, North Ostrobothnia, Finlândia, 90220
        • Oulun yliopistollinen sairaala /ID# 253969
    • Pirkanmaa
      • Tampere, Pirkanmaa, Finlândia, 33100
        • Terveystalo Tampere /ID# 253968
    • Alpes-Maritimes
      • Nice, Alpes-Maritimes, França, 06202
        • Chu De Nice-Hopital Larchet II /ID# 253504
    • Gironde
      • Bordeaux, Gironde, França, 33000
        • Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Saint-Andre /ID# 254139
    • Marne
      • Reims, Marne, França, 51100
        • Polyclinique Courlancy /ID# 254680
    • Pays de la Loire Region
      • Nantes, Pays de la Loire Region, França, 44000
        • Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 254114
    • Rhone
      • Lyon, Rhone, França, 69003
        • HCL - Hopital Edouard Herriot /ID# 253500
    • Île-de-France Region
      • Antony, Île-de-France Region, França, 92160
        • Hopital Prive d'Antony /ID# 253501
      • Thessaloniki, Grécia, 54643
        • Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 253497
      • Thessaloniki, Grécia, 56429
        • Papageorgiou General Hospital /ID# 253496
    • Attica
      • Athens, Attica, Grécia, 11527
        • 401 GSNA - 401 Army General Hospital /ID# 253499
      • Athens, Attica, Grécia, 16121
        • General Hospital Andreas Syggros /ID# 253498
      • Chaïdári, Attica, Grécia, 12462
        • University General Hospital Attikon /ID# 253495
      • Groningen, Holanda, 9713 GZ
        • Universitair Medisch Centrum Groningen /ID# 253571
    • North Brabant
      • Breda, North Brabant, Holanda, 4818 CK
        • Amphia Ziekenhuis /ID# 253567
      • Budapest, Hungria, 1027
        • Csalogany Orvosi Kozpont /ID# 255063
      • Budapest, Hungria, 1036
        • Duplicate_Obudai Egeszsegugyi Centrum Kft. /ID# 256366
      • Budapest, Hungria, 1085
        • Semmelweis Egyetem /ID# 276162
      • Debrecen, Hungria, 4031
        • DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 253638
    • Baranya
      • Pécs, Baranya, Hungria, 7624
        • Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 253753
    • Csongrád megye
      • Szeged, Csongrád megye, Hungria, 6720
        • Szegedi Tudomanyegyetem /ID# 255142
    • Hajdú-Bihar
      • Debrecen, Hajdú-Bihar, Hungria, 4032
        • Debreceni Egyetem-Klinikai Kozpont /ID# 253637
    • Somogy County
      • Kaposvár, Somogy County, Hungria, 7400
        • Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 253913
    • Vas County
      • Szombathely, Vas County, Hungria, 9700
        • Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 254377
      • Cork, Irlanda, T12 X23H
        • South Infirmary Victoria University Hospital /ID# 253975
      • Dublin, Irlanda, D04 T6F4
        • St. Vincent's University Hospital /ID# 253971
      • Galway, Irlanda, H91 YR71
        • University Hospital Galway /ID# 253976
      • Waterford, Irlanda, X91 ER8E
        • Waterford Regional Hospital /ID# 254038
    • Dublin
      • Dublin, Dublin, Irlanda, D08 NHY1
        • St James Hospital /ID# 253973
      • Haifa, Israel, 3109601
        • Rambam Health Care Campus /ID# 254406
    • Central District
      • Petah Tikva, Central District, Israel, 4941492
        • Rabin Medical Center. /ID# 254405
    • Northern District
      • Safed, Northern District, Israel, 13100
        • ZIV Medical Center /ID# 254403
    • Tel Aviv
      • Ramat Gan, Tel Aviv, Israel, 52621
        • Sheba Medical Center /ID# 254545
      • Tel Aviv, Tel Aviv, Israel, 6423906
        • Tel Aviv Sourasky Medical Center /ID# 254404
      • Brescia, Itália, 25123
        • ASST degli Spedali Civili di Brescia /ID# 254875
      • Milan, Itália, 20122
        • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 254502
      • Modena, Itália, 41124
        • Azienda Ospedaliero-Universitaria di Modena /ID# 254874
      • Pisa, Itália, 56126
        • Azienda Ospedaliero Universitaria Pisana /ID# 254501
    • Ferrara
      • Cona, Ferrara, Itália, 44124
        • Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale S.Anna /ID# 254496
    • Firenze
      • Florence, Firenze, Itália, 50122
        • AZIENDA USL TOSCANA CENTRO - Ospedale Piero Palagi /ID# 254495
    • L Aquila
      • L’Aquila, L Aquila, Itália, 67100
        • ASL 1 Abruzzo - Ospedale regionale San Salvatore /ID# 276045
    • Roma
      • Rome, Roma, Itália, 00133
        • Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 254498
      • Rome, Roma, Itália, 00168
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 254500
    • Fukuoka
      • Fukuoka, Fukuoka, Japão, 814-0180
        • Fukuoka University Hospital /ID# 254729
    • Hyōgo
      • Nishinomiya-shi, Hyōgo, Japão, 663-8186
        • Meiwa Hospital /ID# 254728
    • Ibaraki
      • Tsukuba, Ibaraki, Japão, 305-8576
        • University of Tsukuba Hospital /ID# 254638
    • Kyoto
      • Kyoto, Kyoto, Japão, 602-8566
        • University Hospital Kyoto Prefectural University of Medicine /ID# 254481
    • Miyagi
      • Sendai, Miyagi, Japão, 9808574
        • Tohoku University Hospital /ID# 254598
    • Okinawa
      • Ginowan-shi, Okinawa, Japão, 901-2725
        • University of the Ryukyus Hospital /ID# 254517
    • Osaka
      • Sakai-shi, Osaka, Japão, 590-0197
        • Kindai University Hospital /ID# 254574
    • Shiga
      • Ōtsu, Shiga, Japão, 520-2192
        • Shiga University of Medical Science Hospital /ID# 254215
    • Tokyo
      • Minato-ku, Tokyo, Japão, 105-8470
        • Toranomon Hospital /ID# 253819
      • tabashi City, Tokyo, Japão, 173-8610
        • Nihon University Itabashi Hospital /ID# 254637
      • Vilnius, Lituânia, 08406
        • Inlita - Santara KTC /ID# 253917
      • Vilnius, Lituânia, 08661
        • Vilnius University Hospital Santaros Klinikos /ID# 253916
      • Mexico City, México, 06100
        • Cryptex Investigacion Clinica S.A de C.V /ID# 256066
    • Jalisco
      • Guadalajara, Jalisco, México, 44657
        • Grupo Clinico Catei Sociedad Civil /Id# 254657
    • Nuevo León
      • Monterrey, Nuevo León, México, 64718
        • Eukarya PharmaSite, SC /ID# 254658
    • Auckland
      • Epsom, Auckland, Nova Zelândia, 1051
        • Greenlane Clinical Centre /ID# 254351
    • Waikato Region
      • Hamilton, Waikato Region, Nova Zelândia, 3204
        • Clinical Trials New Zealand /ID# 254352
      • Caguas, Porto Rico, 00727
        • Dr. Samuel Sanchez PSC /ID# 253948
      • Carolina, Porto Rico, 00985
        • Alma M. Cruz Santana, MD-Private practice /ID# 253951
      • Lisbon, Portugal, 1998-018
        • Hospital CUF Descobertas /ID# 254323
      • Porto, Portugal, 4099-001
        • Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 254322
      • Porto, Portugal, 4200-319
        • Unidade Local de Saude Sao Joao /ID# 254324
    • Lisbon District
      • Lisbon, Lisbon District, Portugal, 1169-050
        • Centro Hospitalar de Lisboa Central - Lisbon /ID# 254325
      • Bristol, Reino Unido, BS1 3NU
        • University Hospitals Bristol /ID# 261505
      • Salford, Reino Unido, M6 8HD
        • Northern Care Alliance NHS Group /ID# 256910
    • Greater London
      • Isleworth, Greater London, Reino Unido, TW7 6AF
        • West Middlesex University Hospital /ID# 254190
      • London, Greater London, Reino Unido, SW17 0QT
        • St George University Hospitals NHS Foundation Trust /ID# 256803
    • Hampshire
      • Southampton, Hampshire, Reino Unido, SO16 6YD
        • University Hospital Southampton NHS Foundation Trust /ID# 254531
    • Warwickshire
      • Coventry, Warwickshire, Reino Unido, CV2 2DX
        • UH Coventry & Warwickshire /ID# 256909
    • West Yorkshire
      • Leeds, West Yorkshire, Reino Unido, LS9 7TF
        • Leeds Teaching Hospitals NHS Trust /ID# 254616
    • Stockholm County
      • Solna, Stockholm County, Suécia, 171 64
        • Karolinska University Hospital Solna /ID# 254808
    • Västra Götaland County
      • Gothenburg, Västra Götaland County, Suécia, 413 46
        • Sahlgrenska Universitetssjukhuset /ID# 254807
      • Bern, Suíça, 3010
        • Inselspital, Universitaetsspital Bern /ID# 254736
    • Canton of St. Gallen
      • Sankt Gallen, Canton of St. Gallen, Suíça, 9007
        • Kantonsspital St. Gallen /ID# 255243
    • Canton of Zurich
      • Zurich, Canton of Zurich, Suíça, 8091
        • University Hospital Zurich /ID# 254642
      • Changhua City, Changhua County, Taiwan, 50006
        • Changhua Christian Hospital /ID# 254032
      • Kaohsiung City, Taiwan, 833
        • Kaohsiung Chang Gung Memorial Hospital /ID# 254031
      • Taipei, Taiwan, 100
        • National Taiwan University Hospital /ID# 254030
      • Taoyuan City, Taiwan, 333
        • Linkou Chang Gung Memorial Hospital /ID# 254033
      • Karlovy Vary, Tcheca, 360 01
        • Karlovarska Krajska Nemocnice - Karlovy Vary /ID# 253456
      • Prague, Tcheca, 100 34
        • Fakultni nemocnice Kralovske Vinohrady /ID# 253454
    • Praha 5
      • Prague, Praha 5, Tcheca, 150 06
        • Fakultni nemocnice Motol a Homolka /ID# 253455
      • Bayraklı, Turquia (Türkiye), 35540
        • Izmir Sehir Hastanesi /ID# 265465
      • Bursa, Turquia (Türkiye), 16059
        • Uludag University Medical Faculty /ID# 253806
      • Istanbul, Turquia (Türkiye), 34098
        • Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi /ID# 253824
      • Kayseri, Turquia (Türkiye), 38039
        • Erciyes University Medical Faculty /ID# 253804
      • Samsun, Turquia (Türkiye), 55139
        • Ondokuz Mayis Universitesi /ID# 254034
    • Antalya
      • Ankara, Antalya, Turquia (Türkiye), 06010
        • Gulhane Egitim ve Arastirma Hastanesi /ID# 253919
    • State of Vienna
      • Vienna, State of Vienna, Áustria, 1090
        • Medizinische Universitaet Wien /ID# 254096
    • Styria
      • Graz, Styria, Áustria, 8010
        • Medizinische Universitaet Graz /ID# 253448
    • Upper Austria
      • Linz, Upper Austria, Áustria, 4010
        • Duplicate_Ordensklinikum Linz GmbH Elisabethinen /ID# 253458

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

12 anos e mais velhos (Filho, Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Diagnosis of hidradenitis suppurativa (HS) for at least 6 months prior to Baseline, as determined by the investigator (i.e., through medical history and interview of participant).
  • Documented history of previous use of >= 1 tumor necrosis factor (TNF) inhibitor for HS for at least 12 weeks and/or 1 approved non-anti-TNF biologic therapy for HS for at least 16 weeks characterized by inadequate response or for any duration characterized by intolerance as determined by the investigator.
  • Participant must have a total abscess and inflammatory nodule (AN) count of >= 5 at Baseline.
  • HS lesions must be present in at least 2 distinct anatomic areas at Baseline.
  • At least 1 anatomic area of HS involvement characterized as Hurley Stage II or higher at Baseline.
  • Draining fistula count of <= 20 at Baseline.

Exclusion Criteria:

  • History of active skin disease other than HS that could interfere with the assessment of HS, including skin infections (bacterial, fungal, or viral) requiring systemic treatment within 4 weeks of the Baseline visit.
  • Treatment with any investigational drug of chemical or biologic nature within a minimum of 30 days or 5 half-lives (whichever is longer) prior to the first dose of study drug or be currently enrolled in another interventional clinical study. Investigational drugs are also prohibited during the study.
  • Previous treatment with any cell-depleting therapies including but not limited to anti-CD20 (e.g., rituximab) within 12 months prior to Baseline or until B cell count returns to normal level or pre-treatment level.
  • Use of prescription topical therapies (including topical antibiotics) that can also be used to treat HS within 14 days prior to the Baseline visit.
  • Received any systemic (including oral) antibiotic treatment for HS or any other chronic inflammatory disorder within 14 days prior to the Baseline visit.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Quadruplicar

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Period 1: Upadacitinib Dose A

Participants will receive Upadicitinib Dose A once daily for 16 weeks.

Oral Tablets

Outros nomes:
  • RINVOQ
  • ABT-494
Comparador de Placebo: Period 1: Placebo

Participants will receive Placebo once daily for 16 weeks.

Oral Tablets

Experimental: Period 2: Group 1 - Upadacitinib Dose A

Participants who were randomized to placebo in Period 1 who did not achieve HiSCR 50 (clinical non-responder, CNR) at Week 16 will receive Upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Outros nomes:
  • RINVOQ
  • ABT-494
Comparador de Placebo: Period 2: Group 2 - Placebo

Participants who were randomized to placebo in Period 1 who achieve HiSCR 50 (clinical responder, CR) at Week 16 will continue to receive placebo once daily for 20 weeks.

Oral Tablets

Experimental: Period 2: Group 3 - Upadacitinib Dose A

Participants who were randomized to upadacitinib Dose A in Period 1 who did not achieve HiSCR 50 (CNR) at Week 16 will continue to receive upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Outros nomes:
  • RINVOQ
  • ABT-494
Experimental: Period 2: Group 4 - Upadacitinib Dose A

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Outros nomes:
  • RINVOQ
  • ABT-494
Experimental: Period 2: Group 5 - Upadacitinib Dose B

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose B once daily for 20 weeks.

Oral Tablets

Outros nomes:
  • RINVOQ
  • ABT-494
Experimental: Period 2: Group 6 - Placebo

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive placebo once daily for 20 weeks.

Oral Tablets

Experimental: Period 3: Long-Term Extension

Eligible participants will continue to receive upadacitinib or placebo for 68 weeks. Participants will be followed-up for approximately 30 days.

Oral Tablets

Outros nomes:
  • RINVOQ
  • ABT-494

Oral Tablets

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 50
Prazo: Baseline to Week 16

HiSCR 50 is defined as at least a 50% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline.

Baseline to Week 16
Number of Participants with Adverse Events (AEs)
Prazo: Up to Approximately Week 108

An AE is defined as any untoward medical occurrence in a patient or clinical investigation in which a participant is administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment.

Up to Approximately Week 108

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change from Baseline in Draining Fistula Count
Prazo: Baseline to Week 16

Change from baseline in draining fistula count.

Baseline to Week 16
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 75
Prazo: Baseline to Week 16

HiSCR 75 is defined as at least a 75% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline.

Baseline to Week 16
Percentage of Participants Achieving Numeric Rating Scale 30 (NRS30) at Week 4 Among Participants with NRS ≥ 3 at Baseline
Prazo: Baseline to Week 4

Achievement will be considered at least a 30% reduction and at least 2 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine).

Baseline to Week 4
Percentage of Participants Achieving NRS3 at Week 4 Among Participants with NRS ≥ 3 at Baseline
Prazo: Baseline to Week 4

Achievement will be considered least 3 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine).

Baseline to Week 4
Change from Baseline in Hidradenitis Suppurativa Symptom Assessment (HSSA)
Prazo: Baseline to Week 16

The HSSA (24-hour recall) is a 9-item PRO questionnaire developed to assess the primary symptoms of HS in the 7 consecutive days prior to assessments. Each item of the HSSA is scored on an 11-point (0 to 10) NRS, where 0 represents no symptoms and 10 represents extreme symptom experience.

Baseline to Week 16
Change from Baseline in Hidradenitis Suppurativa Impact Assessment (HSIA)
Prazo: Baseline to Week 16

The HSIA is an 18-item PRO questionnaire developed to assess the impact of HS on the daily lives of subjects in the 7 days prior to the assessment. Items 1 - 16 of the HSIA are scored on a 0 to 10 NRS, where 0 represents no impact and 10 represents extreme impact.

Baseline to Week 16
Change from Baseline in Dermatology Life Quality Index (DLQI) for Adult Participants and Adolescent Participants Age ≥16 Years Old and Older
Prazo: Baseline to Week 16

The DLQI and the CDLQI are both 10-item questionnaires used to assess the impact of hidradenitis suppurativa (HS) disease symptoms and treatment on quality of life that consists of 10 questions scored on a 4-point scale where 0 = not at all/not relevant; 1 = a little; 2 = a lot; and 3 = very much.

Baseline to Week 16
Occurrence of Hidradenitis Suppurativa (HS) Flare During Period 1
Prazo: Baseline to Week 16

Defined as at least one occurrence of a ≥ 25% increase in AN count, with a minimum absolute increase of 2 relative to Baseline.

Baseline to Week 16

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Diretor de estudo: ABBVIE INC., AbbVie

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

21 de junho de 2023

Conclusão Primária (Estimado)

1 de agosto de 2028

Conclusão do estudo (Estimado)

1 de agosto de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

26 de maio de 2023

Enviado pela primeira vez que atendeu aos critérios de CQ

26 de maio de 2023

Primeira postagem (Real)

5 de junho de 2023

Atualizações de registro de estudo

Última Atualização Postada (Real)

13 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

10 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information.

Prazo de Compartilhamento de IPD

For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/

Critérios de acesso de compartilhamento IPD

To learn more about the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Sim

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever